Management of rapidly progressive glomerulonephritis

Richard Glassock, William L Henrich

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Serologic studies now permit early and easy identification of renal vasculitis, and current treatment regimens boast short-term survival rates of greater than 85%. Still, achieving an optimal outcome requires that the diagnostic process be set in motion promptly, before the disease causes irreversible renal damage.

Original languageEnglish (US)
Pages (from-to)59-71
Number of pages13
JournalHospital Practice
Volume35
Issue number2
StatePublished - Feb 15 2000
Externally publishedYes

Fingerprint

Glomerulonephritis
Kidney
Vasculitis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Management of rapidly progressive glomerulonephritis. / Glassock, Richard; Henrich, William L.

In: Hospital Practice, Vol. 35, No. 2, 15.02.2000, p. 59-71.

Research output: Contribution to journalArticle

Glassock, Richard ; Henrich, William L. / Management of rapidly progressive glomerulonephritis. In: Hospital Practice. 2000 ; Vol. 35, No. 2. pp. 59-71.
@article{79cd92d73c7e4fd1832b7d617aa7885e,
title = "Management of rapidly progressive glomerulonephritis",
abstract = "Serologic studies now permit early and easy identification of renal vasculitis, and current treatment regimens boast short-term survival rates of greater than 85{\%}. Still, achieving an optimal outcome requires that the diagnostic process be set in motion promptly, before the disease causes irreversible renal damage.",
author = "Richard Glassock and Henrich, {William L}",
year = "2000",
month = "2",
day = "15",
language = "English (US)",
volume = "35",
pages = "59--71",
journal = "Hospital practice (1995)",
issn = "2154-8331",
publisher = "Taylor and Francis Ltd.",
number = "2",

}

TY - JOUR

T1 - Management of rapidly progressive glomerulonephritis

AU - Glassock, Richard

AU - Henrich, William L

PY - 2000/2/15

Y1 - 2000/2/15

N2 - Serologic studies now permit early and easy identification of renal vasculitis, and current treatment regimens boast short-term survival rates of greater than 85%. Still, achieving an optimal outcome requires that the diagnostic process be set in motion promptly, before the disease causes irreversible renal damage.

AB - Serologic studies now permit early and easy identification of renal vasculitis, and current treatment regimens boast short-term survival rates of greater than 85%. Still, achieving an optimal outcome requires that the diagnostic process be set in motion promptly, before the disease causes irreversible renal damage.

UR - http://www.scopus.com/inward/record.url?scp=0034651919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034651919&partnerID=8YFLogxK

M3 - Article

C2 - 10689390

AN - SCOPUS:0034651919

VL - 35

SP - 59

EP - 71

JO - Hospital practice (1995)

JF - Hospital practice (1995)

SN - 2154-8331

IS - 2

ER -